Trial Profile
A Study to Evaluate the Efficacy and Safety of Perampanel in Patients With Refractory Status Epilepticus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 22 Mar 2016 New trial record